Fueled by theranostics, new radiopharmaceutical therapies to treat cancer are advancing at a blistering pace. To help keep up with the dynamic landscape, AuntMinnie has launched the Radiopharmaceutical Therapy Tracker.
Most of these drugs are in registered early-phase studies, and we’ve linked directly to details. Where we’ve covered a therapeutic or imaging agent, we’ve included a link to the story, as well as an option to browse relevant news.
With estimates suggesting that up to 300 new radiopharmaceuticals are currently in development, this tracker is just the beginning. We’ll update it continuously as the pipeline grows. Readers with new entries or updates are welcome to reach us at editorial@auntminnie.com.